Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
BM |
|
Oxley Holdings Ltd
SGX:5UX
|
SG |
|
Q
|
Quest Holdings SA
ATHEX:QUEST
|
GR |
|
H.U. Group Holdings Inc
TSE:4544
|
JP |
|
Dexterra Group Inc
TSX:DXT
|
CA |
|
Kingboard Holdings Ltd
HKEX:148
|
HK |
|
Elite Pharmaceuticals Inc
OTC:ELTP
|
US |
Wall Street
Price Targets
KNSA Price Targets Summary
Kiniksa Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
KNSA
is 56.97 USD
with a low forecast of 50.5 USD and a high forecast of 65.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is KNSA's stock price target?
Price Target
56.97
USD
According to Wall Street analysts, the average 1-year price target for
KNSA
is 56.97 USD
with a low forecast of 50.5 USD and a high forecast of 65.1 USD.
What is Kiniksa Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
23%
The
compound annual growth rate
of Kiniksa Pharmaceuticals Ltd's revenue for the next 3 years is
23%.
What is Kiniksa Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
38%
The
compound annual growth rate
of Kiniksa Pharmaceuticals Ltd's operating income for the next 3 years is
38%.
What is Kiniksa Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
46%
The
compound annual growth rate
of Kiniksa Pharmaceuticals Ltd's net income for the next 3 years is
46%.
